VANGUARD GROUP INC - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 1 filers reported holding F-STAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,849,636
+15.6%
292,664
-6.4%
0.00%
Q3 2022$1,600,000
-71.3%
312,608
-64.8%
0.00%
Q2 2022$5,566,000
+162.1%
889,253
+48.6%
0.00%
Q1 2022$2,124,000
-43.4%
598,437
-20.0%
0.00%
Q4 2021$3,754,000
-31.1%
747,700
+0.4%
0.00%
Q3 2021$5,451,000
-17.9%
744,623
-3.7%
0.00%
Q2 2021$6,642,000
+16.1%
773,215
+46.3%
0.00%
Q1 2021$5,723,000
+49.4%
528,489
+36.2%
0.00%
Q4 2020$3,830,000388,0480.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 714,285$6,136,0001.28%
Boxer Capital, LLC 1,751,428$15,045,0000.53%
Atlas Venture Advisors, Inc. 574,996$4,939,0000.51%
Monashee Investment Management LLC 400,000$3,436,0000.41%
Connolly Sarah T. 53,001$455,0000.37%
Rock Springs Capital Management LP 1,054,232$9,056,0000.18%
Eversept Partners, LP 100,000$859,0000.06%
Maven Securities LTD 144,932$1,257,0000.05%
Point72 Asset Management, L.P. 1,075,000$9,234,0000.04%
Private Capital Advisors, Inc. 13,083$112,0000.02%
View complete list of F-STAR THERAPEUTICS INC shareholders